Jeffrey Dierks sold $389K of Harmony Biosciences (HRMY)

Executed Jan 15 2025, disclosed Jan 16 2025, 1 day later.

Value, as filed

$389K

10,507 sh × $37.01

Executed

Jan 15 2025

the trade date, as filed

Disclosed

Jan 16 2025

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Jeffrey Dierks CHIEF COMMERCIAL OFFICER profile →

Jeffrey Dierks (CHIEF COMMERCIAL OFFICER) filed 8 Form 4 reports in the past 24 months (0 purchases, 8 sales), most often in Harmony Biosciences Holdings, Inc. (HRMY). The largest single filing was $1.4M of HRMY (35,846 sh × $40.03, as filed), executed Sep 30 2024.

The name

HRMY

Harmony Biosciences Holdings, Inc. HRMY · Healthcare · 21 filings in 24 months ticker →

Healthcare · Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for pati…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Jeffrey Dierks in HRMY

HRMYSALE Harmony Biosciences Holdings, Inc. $142K
4,369 sh × $32.61
Exec Mar 3 2025
Filed Mar 5 2025 · 5:30 PM ET HRMYSALE Harmony Biosciences Holdings, Inc. $490K
13,125 sh across 2 lots
Exec Jan 24 2025
Filed Jan 28 2025 · 5:30 PM ET HRMYSALE Harmony Biosciences Holdings, Inc. $1.1M
29,475 sh × $37.41
Exec Jan 16 2025
Filed Jan 21 2025 · 5:30 PM ET HRMYSALE Harmony Biosciences Holdings, Inc. $266K
7,180 sh × $37.04
Exec Jan 13 2025
Filed Jan 15 2025 · 5:30 PM ET HRMYSALE Harmony Biosciences Holdings, Inc. $870K
21,496 sh × $40.47
Exec Oct 29 2024
Filed Oct 31 2024 · 5:30 PM ET HRMYSALE Harmony Biosciences Holdings, Inc. $1.2M
35,652 sh × $35.05
Exec Oct 3 2024
Filed Oct 7 2024 · 5:30 PM ET HRMYSALE Harmony Biosciences Holdings, Inc. $1.4M
35,846 sh × $40.03
Exec Sep 30 2024
Filed Oct 1 2024 · 5:30 PM ET